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13. Other issues 
[~ Multiple brain abscesses in Cystic Fibrosis 
J. Gjevre, M. Fenton, R. Taylor-Gjevre, D. Cockcroft. Dept of Medicine, University 
of Saskatchewan, Saskatoon, SK, Canada 
Aims: To describe asevere complication of cystic fibrosis involving cerebral abscess 
formation. 
Methods: An 18 year old male diagnosed with cystic fibrosis at age 8 months 
presented with a 3 week history of fever, cough, and sputum. He was known to 
be colonized with Klebsiella pneumoniae and Pseudomonas aeruginosa (mucoid 
strain) and was chronically on nebulized tobramycin and oral ciprofloxacin. The 
day of admission he rapidly developed bilateral occipital headache, neck pain and 
stiffness, as well as nausea with vomiting. 
Results: The admission WBC was 29K. His chest radiograph showed very severe 
bronchiectasis e sentially destroying the right lung and sputum culture was positive 
for /~ aeruginosa (mucoid strain). The CT head revealed multiple intracranial 
abcesses and left lateral ventriculits. A lumbar puncture revealed purulent fluid but 
culture results were all negative. Despite aggressive antibiotic and neurosurgical 
interventions, the patient deteriorated and died. 
Discussion: Brain abscesses have been rarely reported in patients with cystic fibrosis 
with fewer than 15 reported cases in the English language literature. Predisposing 
factors appear to be sinusitis and immunosuppression. Previous reports have found 
pseudomonas, streptococcus, blastomycosis, and mouth organisms as the infectious 
etiology. In addition, no specific organism was found in some cases. There have 
been only two previous reports of multiple brain abscesses. In only one previous 
report did the patient survive the brain abscess. It is important to consider brain 
abscess in febrile cystic fibrosis patients who have headache or meningeal symptoms 
and start antibiotic therapy promptly. 
S109 
~A longitudinal study of bone mineral density change in adults 
with Cystic Fibrosis 
G.S. Tomlinson 1 , G. MacGregor 1 , M. Fairhurst 2, M.E. Hodson 2, S.L. Elkin 2. 
1Department of ResTiratory Medicine, Gartnavel General Hospital, Glasgow, 
Scotland; 2Department of Cystic Fibrosis', Royal Brompton Hospital London, 
England, UK 
Aims: Significant declines in bone mineral density (BMD) have been reported in 
adults with cystic fibrosis (CF) but longitudinal data greater than 1 year are scarce. 
The aim of this study was to document changes in BMD over a 3 4 year period 
and to investigate associated factors. 
Methods: Data were collected from dual energy x-ray absorptiometry (DXA) scans 
in 86 CF adults (48 male, mean age 35.9). Absolute BMD (g/cm 2) of the total hip 
(TH), femoral neck (FN) and lumbar spine (LS) were recorded at 2 time points, 3 4 
years apart. FEV1, Body Mass Index (BMI), number of intravenous (IV) antibiotics, 
steroid use, serum 25 OHD and testosterone l vels were also recorded. 
Results: BMD dropped significantly over 4 years at the FN (p 0.016), but not 
at the TH or LS. The median % change was 5.28% (IQR 10.15 1.84) at the 
FN, 2.45% (IQR 6.97 0.41) at the TH, and 1.03% (IQR 5.67 1.90) at the 
LS. % Change BMD at the FN correlated with steroid use (p 0.02). % Change 
BMD at the TH correlated with FEV1 (p 0.01), BMI (p 0.003), IV antibiotic 
use (p 0.02) and steroid use (p 0.008). % Change BMD at the LS correlated 
with FEV1 (p 0.01), BMI (p < 0.001) and steroid use (p < 0.001). 21/86 (24.42%) 
lost BMD at 3 sites, 11/86 (12.79%) lost at 2, 24/86 (27.91%) lost at 1 and 30/86 
(34.88%) remained stable or gained bone at all 3 sites. 
Conclusion: Accelerated bone loss occurs to a greater degree at the femoral neck 
and is significantly related to steroid use in adults with CE While bone loss occurs 
in many patients, some remain stable or gain BMD. This should be considered 
before commencing bisphosphonate therapy and supports the use of serial scans to 
document bone loss. 
Kidney pathology in children with Cystic Fibrosis 
V Tolstova, N. Kapranov, E. Neudakhin, N. Kashirskaya. Research Centre for 
Medical Genetics' RAMS, Moscow, Russia 
Aim: To determine the character of kidney disease in children with cystic fibro- 
sis (CF), elaborate its diagnostic riteria and treatment. 
Methods: Included renal ultrasonography, measurements of the urinary concentra- 
tion ofNa+, K+, Ca2+, oxalate, phosphate, urates, creatinine, carbohydrates, urinary 
enzymes. 55 CF patients (1.5 to 16 years old) with severe and moderate disease 
were examined. There was a comparison group; 37 children with connective tissue 
disease (not CF) and a control group; 15 healthy children. 
Results: Pathologies characterized as metabolic nephropathy were disclosed in 
80% of CF subjects. Urinalysis showed various transitory pathologies (including 
protein-, leukocyte-, and hematuria) in 40% of CF children. The increase of 
occurrence of hyperoxaluria and calciuria was reliably determined in the older 
patients. Ultrasonography data indicated that in patients >5 yrs the increase of the 
echogenicity of kidney parenchyma and reduction of layer differenciation occurred 
more often. Uraturia and calcium-oxaluria, elevated excretion of carbohydrates and 
ultrasound evidences of nephropaty occurred more often in the subjects with severe 
CF than in those with moderate one. Irrespective of the age CF children showed the 
elevated activity of urine enzymes: lactatdehydrohenase, lkaline phosphatase and 
gammaglutamyltransferase. These results uggested the localization of the pathology 
in the renal proximal tubules and Henle loop. Metabolic nephropathy was suc- 
cessfully treated by membrane-stabilizing diphosphonate "Ksidifon", 15 mg/kg/day, 
administrated in the second half of a day, for 1 month. 
Conclusion: We conclude that metabolic nephropathy is a widespread isease in 
CF subjects. The probable reasons long-term therapy with nephrotoxic drugs and 
hypoxia leading to the cell membrane destabilization. 
~The determinants of daily physical activity (in steps/day) in 
Cystic Fibrosis patients: an observational study 
J. Kraan 1 , E. de Graaf 2, W Hoogeveen 2, J.G. Nomden 3, M.M. van den Briel 3, 
B. Koster 4, J.C. ter Maaten 4, M.H.G. de Greef 2. 1Department of Pulmonary 
Diseases of the University Medical Center Groningen (UMCG), 2Center of Human 
Movement Sciences', University Groningen (RUG), 3Center for Rehabilitation of 
the UMCG, 4Department of Internal Medicine of the UMCG, Groningen, The 
Netherlands 
Study Objective: To examine the determinants of daily physical activity in patients 
with Cystic Fibrosis (CF) 
Methods: Nineteen adults (13/6 m/f, age 30.2±7.0 (S.D) yrs) with CF were enrolled 
in an observational cross-sectional study. A pedometer (Digiwalker SW-200) was 
used for four weeks by the subjects to assess daily physical activity. Pulmonary 
function (FEV1;VC), lean weight, and BMI were measured. Dyspnea was assessed 
with the MRC dyspnea scale, health-related quality of life with the CF Questionnaire 
(CFQ 14+), exercise capacity with the 12-level Shuttle Walk Test (SWT) and lower- 
body strength with the Chair Stand Test (CST). 
Results: VC and FEV1 were 75±17% and 47±19% of predicted. BMI averaged 
21.5±3.1. The subjects walked 728±280m. in the SWT (maximum of the test 
1020m). Pedometer measurements showed an average number of 7409 (±3548) 
steps/day. This mean number of steps is not different from values found in healthy 
subjects. There was a large inter-individual, but a small intra-individual variation 
in steps. There was also some variation in steps made related to daily outdoor 
temperature. Exercise capacity (SWT), dyspnea nd FEV1 were (significantly) the 
most relevant predictors of steps measured by pedometer. 
Conclusions: Mean daily physical activity status measured as steps/day with a 
pedometer in CF patients does not differ from healthy subjects. Exercise capacity, 
FEV1, and dyspnea score are determinants of physical activity (steps/day) in CF 
patients. 
